Swiss pharma company, Basilea, receives FDA Qualified Infectious Disease Product designation for fungal drug, isavuconazole
PRESS RELEASE Basilea Pharmaceutica Ltd. announced Thursday that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive More...
Research findings could result in the development of a vaccine and drugs for mucormycosis
PRESS RELEASE Mucormycosis is a deadly infection that strikes people with weakened immune systems when certain types of fungi, called Mucorales, invade the patients’ cells. A novel protein on the surface of the More...
The possible aftermath of the Oklahoma tornados: the risk of fungal infections
In the aftermath of the tornados that ripped through parts of Oklahoma killing dozens, including children, is the risk of serious, potentially fatal, deep skin fungal infections. In a scene reminiscient of Joplin, More...
